Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Birte Wistinghausen, Thomas G. Gross & Catherine Bollard. (2013) Post-Transplant Lymphoproliferative Disease in Pediatric Solid Organ Transplant Recipients. Pediatric Hematology and Oncology 30:6, pages 520-531.
Read now
Read now
Mary M. Taj, Nedim Hadzic, Susan E. Height, Andrew Wotherspoon, Margaret Burke, Rachel Hobson, Maria Viskaduraki & C. Ross Pinkerton. (2012) Long-term outcome for immune suppression and immune related lymphoproliferative disorder: prospective data from the United Kingdom Children's Leukaemia and Cancer Group registry 1994–2004. Leukemia & Lymphoma 53:5, pages 842-848.
Read now
Read now
Articles from other publishers (26)
Apostolia Papalexandri, Eleni Gavriilaki, Anna Vardi, Nikolaos Kotsiou, Christos Demosthenous, Natassa Constantinou, Tasoula Touloumenidou, Panagiota Zerva, Fotini Kika, Michalis Iskas, Ioannis Batsis, Despina Mallouri, Evangelia Yannaki, Achilles Anagnostopoulos & Ioanna Sakellari. (2023) Pre-Emptive Use of Rituximab in Epstein–Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes. International Journal of Molecular Sciences 24:22, pages 16029.
Crossref
Crossref
Lorenzo ZaffiriEileen T. Chambers. (2023) Screening and Management of PTLD. Transplantation 107:11, pages 2316-2328.
Crossref
Crossref
Ivona Nečasová, Martin Stojaspal, Edita Motyčáková, Tomáš Brom, Tomáš Janovič & Ctirad Hofr. (2022) Transcriptional regulators of human oncoviruses: structural and functional implications for anticancer therapy. NAR Cancer 4:1.
Crossref
Crossref
Zeineb Zian, S.P. Déo-Gracias Berry, Nazila Bahmaie, Dana Ghotbi, Ali Kashif, Manisha Madkaikar, Umair Ahmed Bargir, Hamisu Abdullahi, Haroon Khan & Gholamreza Azizi. (2021) The clinical efficacy of Rituximab administration in autoimmunity disorders, primary immunodeficiency diseases and malignancies. International Immunopharmacology 95, pages 107565.
Crossref
Crossref
Nedim Hadžić. 2021. Liver Disease in Children. Liver Disease in Children
383
400
.
Michael D. Green, Thomas GrossJr.Jr. & Upton D. Allen. 2021. Pediatric Transplant and Oncology Infectious Diseases. Pediatric Transplant and Oncology Infectious Diseases
126
133.e3
.
Ajai Khanna & George V. Mazariegos. 2021. Post-Transplant Lymphoproliferative Disorders. Post-Transplant Lymphoproliferative Disorders
271
282
.
Masaki Yamada, Andrew Nowalk & Michael Green. 2021. Emerging Transplant Infections. Emerging Transplant Infections
655
682
.
Masaki Yamada, Andrew Nowalk & Michael Green. 2020. Emerging Transplant Infections. Emerging Transplant Infections
1
29
.
Upton D. Allen & Jutta K. Preiksaitis. (2019) Post‐transplant lymphoproliferative disorders, Epstein‐Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clinical Transplantation 33:9.
Crossref
Crossref
Ashley V. Geerlinks, Thomas G. Gross & Angela S. Punnett. 2019. Non-Hodgkin's Lymphoma in Childhood and Adolescence. Non-Hodgkin's Lymphoma in Childhood and Adolescence
195
211
.
Kaitlin Stanley, Erika Friehling, Sarangarajan Ranganathan, George Mazariegos, Linda M. McAllister-Lucas & Rakesh Sindhi. (2018) Post-transplant lymphoproliferative disorder in pediatric intestinal transplant recipients: A literature review. Pediatric Transplantation 22:5, pages e13211.
Crossref
Crossref
Neslihan Celik, Kaitlin Stanley, Jeff Rudolph, Feras Al-Issa, Beverly Kosmach, Chethan Ashokkumar, Qing Sun, Renee Brown-Bakewell, Dale Zecca, Kyle Soltys, Ajai Khanna, Geoffrey Bond, Armando Ganoza, George Mazariegos & Rakesh Sindhi. (2018) Improvements in intestine transplantation. Seminars in Pediatric Surgery 27:4, pages 267-272.
Crossref
Crossref
Neel S. Bhatt, Michael E. Kelly, Bjorn Batdorf & Gabriela Gheorghe. (2017) Sinusoidal CD30+ diffuse large B-cell lymphoma can masquerade as anaplastic large cell lymphoma in pediatric posttransplant lymphoproliferative disorders. Pediatric Blood & Cancer 64:8, pages e26403.
Crossref
Crossref
Allison F. O'Neill, Eelam A. Adil, Alexandria L. Irace, Laura Neff, Ian J. Davis, Antonio R. Perez-Atayde, Stephan D. Voss, Olga Weinberg & Reza Rahbar. (2016) Post-transplant lymphoproliferative disorder of the pediatric airway: Presentation and management. International Journal of Pediatric Otorhinolaryngology 86, pages 218-223.
Crossref
Crossref
Mark A. Vickers, Gwen M. Wilkie, Nicolas Robinson, Nadja Rivera, Tanzina Haque, Dorothy H. Crawford, Jacqueline Barry, Neil Fraser, David M. Turner, Victoria Robertson, Phil Dyer, Peter Flanagan, Helen R. Newlands, John Campbell & Marc L. Turner. (2014) Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease. British Journal of Haematology 167:3, pages 402-410.
Crossref
Crossref
Nedim Hadžić. 2014. Liver Disease in Children. Liver Disease in Children
370
386
.
M. Uhlin, J. Gertow, M. Uzunel, M. Okas, S. Berglund, E. Watz, M. Brune, P. Ljungman, M. Maeurer & J. Mattsson. (2012) Rapid Salvage Treatment With Virus-Specific T Cells for Therapy-Resistant Disease. Clinical Infectious Diseases 55:8, pages 1064-1073.
Crossref
Crossref
Austen Worth, Rachel Conyers, Jonathon Cohen, Mamta Jagani, Robert Chiesa, Kanchana Rao, Nicholas Goulden, Paul Veys & Persis J. Amrolia. (2011) Pre‐emptive rituximab based on viraemia and T cell reconstitution: a highly effective strategy for the prevention of Epstein–Barr virus‐associated lymphoproliferative disease following stem cell transplantation. British Journal of Haematology 155:3, pages 377-385.
Crossref
Crossref
Y. Li, S. Huang, X. Wang, D. Zhou, K. Huang, H. Guo, J. Fang, C. Chen & Q. Liu. (2010) Rituximab Combined with Autologous Peripheral Blood Stem Cell Transplantation Improve Therapeutic Effects of Chemotherapy in Pediatric Patients with Burkitt's Lymphoma. Journal of Tropical Pediatrics 56:5, pages 337-341.
Crossref
Crossref
Jennifer Brewin, Christoph Mancao, Karin Straathof, Helen Karlsson, Sujith Samarasinghe, Persis J. Amrolia & Martin Pule. (2009) Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease. Blood 114:23, pages 4792-4803.
Crossref
Crossref
Kevin Windebank, Tom Walwyn, Richard Kirk, Gareth Parry, Asif Hasan, Nick Bown & Bridget Wilkins. (2009) Post cardiac transplantation lymphoproliferative disorder presenting as t(8;14) Burkitt leukaemia/lymphoma treated with low intensity chemotherapy and rituximab. Pediatric Blood & Cancer 53:3, pages 392-396.
Crossref
Crossref
K Masjosthusmann, K Ehlert, B R Eing, J Roth, G Koehler, H Juergens, M Fruehwald & A H Groll. (2008) Delay in B-lymphocyte recovery and function following rituximab for EBV-associated lymphoproliferative disease early post-allogeneic hematopoietic SCT. Bone Marrow Transplantation 43:9, pages 679-684.
Crossref
Crossref
Alfred Reiter & Adolfo A. Ferrando. 2009. Oncology of Infancy and Childhood. Oncology of Infancy and Childhood
417
505
.
Mary M. Taj, Boo Messahel, Julie Mycroft, Kathy Pritchard-Jones, Alistair Baker, Susan Height, Nedim Hadzic & C. Ross Pinkerton. (2007) Efficacy and tolerability of high-dose methotrexate in central nervous system positive or relapsed lymphoproliferative disease following liver transplant in children. British Journal of Haematology 140:2, pages 191-196.
Crossref
Crossref
. (2007) Current Awareness in Hematological Oncology. Hematological Oncology 25:3, pages 148-155.
Crossref
Crossref